Quantitative MRI techniques, including quantitative susceptibility mapping (QSM) and diffusion tensor imaging (DTI), may detect early neurodegenerative changes in ɑ-synucleinopathies, especially within the midbrain. This study evaluated their potential to predict phenoconversion to overt synucleinopathy in 79 patients with isolated REM sleep behavior disorder (iRBD) followed annually over 5.6 ± 3.0 years. Phenoconversion, defined by emergence of parkinsonism or dementia, occurred in 21 patients. Baseline QSM and DTI data were analyzed to identify regional brain differences, revealing increased magnetic susceptibility and fractional anisotropy (FA) in the bilateral cerebral peduncle of phenoconverters. Increased magnetic susceptibility and FA within this region were associated with higher phenoconversion risk (FA: hazard ratio (HR) = 1.84, susceptibility: HR = 1.67). Their combined score predicted phenoconversion with accuracy similar to dopamine-transporter imaging (HR 2.58 vs 2.85). Findings suggest that increased susceptibility and FA in the cerebral peduncle may serve as biomarkers of early phenoconversion, potentially reflecting compensatory neuroplastic changes in subthalamo-pallidal pathways.

3rd Faculty of Medicine Charles University Prague Prague Czech Republic

Department of Circuit Theory Faculty of Electrical Engineering Czech Technical University Prague Prague Czech Republic

Department of Human Neurosciences Sapienza University of Rome Rome Italy

Department of Neurology and Center of Clinical Neuroscience 1st Faculty of Medicine Charles University and General University Hospital Prague Prague Czech Republic

IRCCS Neuromed Pozzilli IS Italy

Radiodiagnostic Department Na Homolce Hospital Prague Czech Republic

Zobrazit více v PubMed

Schenck, C. H., Bundlie, S. R. & Mahowald, M. W. Delayed emergence of a Parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behaviour disorder. PubMed DOI

Iranzo, A., Santamaria, J. & Tolosa, E. Idiopathic rapid eye movement sleep behaviour disorder: diagnosis, management, and the need for neuroprotective interventions. PubMed DOI

Postuma, R. B. et al. Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorder. PubMed DOI PMC

Claassen, D. O. et al. REM sleep behavior disorder preceding other aspects of synucleinopathies by up to half a century(e–Pub ahead of print)(CME). PubMed DOI PMC

Miglis, M. G. et al. Biomarkers of conversion to α-synucleinopathy in isolated rapid-eye-movement sleep behaviour disorder. PubMed DOI PMC

Valli, M., Uribe, C., Mihaescu, A. & Strafella, A. P. Neuroimaging of rapid eye movement sleep behavior disorder and its relation to Parkinson’s disease. PubMed DOI

Bourgouin, P.-A. et al. Neuroimaging of rapid eye movement sleep behavior disorder. PubMed DOI

Heller, J. et al. Brain imaging findings in idiopathic REM sleep behavior disorder (RBD)—a systematic review on potential biomarkers for neurodegeneration. PubMed DOI

Barbosa, J. H. O. et al. Quantifying brain iron deposition in patients with Parkinson’s disease using quantitative susceptibility mapping, R2 and R2*. PubMed DOI

He, N. et al. Region-specific disturbed iron distribution in early idiopathic Parkinson’s disease measured by quantitative susceptibility mapping. PubMed DOI PMC

Langkammer, C. et al. Quantitative susceptibility mapping in Parkinson’s disease. PubMed DOI PMC

Jiang, H., Song, N., Jiao, Q., Shi, L. & Du, X. Iron pathophysiology in Parkinson diseases. PubMed DOI

Mochizuki, H., Choong, C.-J. & Baba, K. Parkinson’s disease and iron. PubMed

Martin, W. R. W., Wieler, M. & Gee, M. Midbrain iron content in early Parkinson disease: a potential biomarker of disease status. PubMed DOI

Chen, Q. et al. MRI quantitative susceptibility mapping of the substantia nigra as an early biomarker for Lewy body disease. PubMed DOI PMC

Lee, J.-H. et al. Evaluation of brain iron content in idiopathic REM sleep behavior disorder using quantitative magnetic resonance imaging. PubMed DOI

Barber, T. R. et al. Nigrosome 1 imaging in REM sleep behavior disorder and its association with dopaminergic decline. PubMed DOI PMC

Sun, J. et al. Quantitative evaluation of iron content in idiopathic rapid eye movement sleep behavior disorder. PubMed DOI

Lancione, M. et al. Evaluation of iron overload in nigrosome 1 via quantitative susceptibility mapping as a progression biomarker in prodromal stages of synucleinopathies. PubMed DOI

Nepozitek, J. et al. Magnetic susceptibility changes in the brainstem reflect REM sleep without atonia severity in isolated REM sleep behavior disorder. PubMed PMC

Lee, J. et al. Sensitivity of MRI resonance frequency to the orientation of brain tissue microstructure. PubMed DOI PMC

Zhang, Y. & Burock, M. A. Diffusion tensor imaging in parkinson’s disease and Parkinsonian syndrome: a systematic review. PubMed DOI PMC

Schuff, N. et al. Diffusion imaging of nigral alterations in early Parkinson’s disease with dopaminergic deficits. PubMed DOI

Chen, N.-K. et al. Alteration of diffusion-tensor magnetic resonance imaging measures in brain regions involved in early stages of Parkinson’s disease. PubMed DOI PMC

Scherfler, C. et al. White and gray matter abnormalities in idiopathic rapid eye movement sleep behavior disorder: a diffusion-tensor imaging and voxel-based morphometry study. PubMed DOI

Unger, M. M. et al. Diffusion tensor imaging in idiopathic REM sleep behavior disorder reveals microstructural changes in the brainstem, substantia nigra, olfactory region, and other brain regions. PubMed DOI PMC

Pyatigorskaya, N. et al. Magnetic resonance imaging biomarkers to assess substantia nigra damage in idiopathic rapid eye movement sleep behavior disorder. PubMed DOI

Holtbernd, F. et al. Convergent patterns of structural brain changes in rapid eye movement sleep behavior disorder and Parkinson’s disease on behalf of the German rapid eye movement sleep behavior disorder study group. PubMed DOI

Arnaldi, D. et al. Dopaminergic imaging and clinical predictors for phenoconversion of REM sleep behaviour disorder. PubMed DOI PMC

Arnaldi, D. et al. Presynaptic dopaminergic imaging characterizes patients with REM sleep behavior disorder due to synucleinopathy. PubMed DOI PMC

Fearnley, J. M. & Lees, A. J. Ageing and Parkinson’s disease: substantia nigra regional selectivity. PubMed DOI

de la Fuente-Fernández, R. et al. Age-specific progression of nigrostriatal dysfunction in Parkinson’s disease. PubMed DOI

Biondetti, E. et al. Spatiotemporal changes in substantia nigra neuromelanin content in Parkinson’s disease. PubMed DOI

de Natale, E. R., Wilson, H. & Politis, M. Predictors of RBD progression and conversion to synucleinopathies. PubMed DOI PMC

Postuma, R. B. et al. Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre study. PubMed DOI PMC

Shin, Y.-W. et al. Predicting phenoconversion in isolated RBD: machine learning and explainable AI approach. PubMed DOI PMC

Li, Y. et al. Predictive markers for early conversion of iRBD to neurodegenerative synucleinopathy diseases. PubMed DOI PMC

Acosta-Cabronero, J., Betts, M. J., Cardenas-Blanco, A., Yang, S. & Nestor, P. J. In vivo MRI mapping of brain iron deposition across the adult lifespan. PubMed DOI PMC

Guan, X. et al. Quantitative susceptibility mapping as a biomarker for evaluating white matter alterations in Parkinson’s disease. PubMed DOI

Ravanfar, P. et al. Systematic review: quantitative susceptibility mapping (QSM) of brain iron profile in neurodegenerative diseases. PubMed PMC

Acosta-Cabronero, J. et al. The whole-brain pattern of magnetic susceptibility perturbations in Parkinson’s disease. PubMed DOI

Varga, Z. et al. Whole brain pattern of iron accumulation in REM sleep behavior disorder. PubMed DOI PMC

Bae, Y. J. et al. Loss of substantia nigra hyperintensity at 3.0-T MR imaging in idiopathic REM sleep behavior disorder: comparison with 123I-FP-CIT SPECT. PubMed DOI

De Marzi, R. et al. Loss of dorsolateral nigral hyperintensity on 3.0 tesla susceptibility-weighted imaging in idiopathic rapid eye movement sleep behavior disorder. PubMed DOI

Zhang, X. et al. Assessing brain iron and volume of subcortical nuclei in idiopathic rapid eye movement sleep behavior disorder. PubMed DOI

Ohlhauser, L., Smart, C. M. & Gawryluk, J. R. Tract-based spatial statistics reveal lower white matter integrity specific to idiopathic rapid eye movement sleep behavior disorder as a proxy for prodromal Parkinson’s disease. PubMed

Pujol, S. et al. In vivo exploration of the connectivity between the subthalamic nucleus and the Globus Pallidus in the human brain using multi-fiber tractography. PubMed PMC

Wisnieff, C. et al. Quantitative susceptibility mapping (QSM) of white matter multiple sclerosis lesions: Interpreting positive susceptibility and the presence of iron. PubMed DOI PMC

Zigmond, M. J., Abercrombie, E. D., Berger, T. W., Grace, A. A. & Stricker, E. M. Compensations after lesions of central dopaminergic neurons: some clinical and basic implications. PubMed DOI

Obeso, J. A. et al. The basal ganglia in Parkinson’s disease: current concepts and unexplained observations. PubMed DOI

Fan, K. Y., Baufreton, J., Surmeier, D. J., Chan, C. S. & Bevan, M. D. Proliferation of external Globus Pallidus-subthalamic nucleus synapses following degeneration of midbrain dopamine neurons. PubMed DOI PMC

Blesa, J. et al. Compensatory mechanisms in Parkinson’s disease: circuits adaptations and role in disease modification. PubMed DOI

Syka, M. et al. Correlation between relaxometry and diffusion tensor imaging in the Globus Pallidus of Huntington’s disease patients. PubMed DOI PMC

Rulseh, A. M., Keller, J., Tintěra, J., Kožíšek, M. & Vymazal, J. Chasing shadows: What determines DTI metrics in gray matter regions? An in vitro and in vivo study. PubMed DOI

Zhu, R., Xie, C., Hu, P. & Wang, K. Clinical variations in Parkinson’s disease patients with or without REM sleep behaviour disorder: a meta-analysis. PubMed DOI PMC

Bušková, J., Ibarburu, V., Šonka, K. & Růžička, E. Screening for REM sleep behavior disorder in the general population. PubMed DOI

Sateia, M. J. International classification of sleep disorders-third edition: highlights and modifications. PubMed DOI

Goetz, C. G. et al. Movement disorder society-sponsored revision of the unified Parkinson’s disease rating scale (MDS-UPDRS): process, format, and clinimetric testing plan. PubMed DOI

Doty, R. L., Shaman, P. & Dann, M. Development of the University of Pennsylvania Smell Identification Test: a standardized microencapsulated test of olfactory function. PubMed DOI

Kopecek, M. et al. Montreal cognitive assessment (MoCA): normative data for old and very old Czech adults. PubMed DOI

Postuma, R. B. et al. MDS clinical diagnostic criteria for Parkinson’s disease. PubMed DOI

Dubois, B. et al. Diagnostic procedures for Parkinson’s disease dementia: recommendations from the movement disorder society task force. PubMed DOI

McKeith, I. G. et al. Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB Consortium. PubMed DOI PMC

Darcourt, J. et al. EANM procedure guidelines for brain neurotransmission SPECT using (123)I-labelled dopamine transporter ligands, version 2. PubMed DOI

Dušek, P. et al. Relations of non-motor symptoms and dopamine transporter binding in REM sleep behavior disorder. PubMed DOI PMC

Eckstein, K. et al. Computationally efficient combination of multi-channel phase data from multi-echo acquisitions (ASPIRE). PubMed DOI

Acosta-Cabronero, J. et al. A robust multi-scale approach to quantitative susceptibility mapping. PubMed DOI PMC

Keller, S. S., Wilke, M., Wieshmann, U. C., Sluming, V. A. & Roberts, N. Comparison of standard and optimized voxel-based morphometry for analysis of brain changes associated with temporal lobe epilepsy. PubMed DOI

Jenkinson, M., Beckmann, C. F., Behrens, T. E. J., Woolrich, M. W. & Smith, S. M. FSL. PubMed DOI

Betts, M. J., Acosta-Cabronero, J., Cardenas-Blanco, A., Nestor, P. J. & Düzel, E. High-resolution characterisation of the aging brain using simultaneous quantitative susceptibility mapping (QSM) and R2* measurements at 7T. PubMed DOI

Faul, F., Erdfelder, E., Lang, A.-G. & Buchner, A. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. PubMed DOI

Robin, X. et al.

Grambsch, P. M. & Therneau, T. M. Proportional hazards tests and diagnostics based on weighted residuals. DOI

Therneau, T. M. A Package for Survival Analysis in R. R package version 3.8-3. https://CRAN.R-project.org/package=survival (2024).

Peduzzi, P., Concato, J., Feinstein, A. R. & Holford, T. R. Importance of events per independent variable in proportional hazards regression analysis II. Accuracy and precision of regression estimates. PubMed DOI